Dabigatran.
作者信息
Murphy L, Lawler L, Kavanagh E C
出版信息
AJNR Am J Neuroradiol. 2011 Nov-Dec;32(10):E195. doi: 10.3174/ajnr.A2850.
Abstract
摘要
相似文献
1
Dabigatran.
AJNR Am J Neuroradiol. 2011 Nov-Dec;32(10):E195. doi: 10.3174/ajnr.A2850.
2
The efficacy and safety of pharmacological prophylaxis of venous thromboembolism following elective knee or hip replacement: systematic review and network meta-analysis.
Clin Appl Thromb Hemost. 2012 Nov;18(6):611-27. doi: 10.1177/1076029612437579. Epub 2012 Mar 2.
3
Thromboprophylaxis with dabigatran leads to an increased incidence of wound leakage and an increased length of stay after total joint replacement.
Bone Joint J. 2014 Jan;96-B(1):122-6. doi: 10.1302/0301-620X.96B1.31569.
4
Dabigatran, rivaroxaban and apixaban versus enoxaparin for thomboprophylaxis after total knee or hip arthroplasty: pool-analysis of phase III randomized clinical trials.
Thromb Res. 2012 Aug;130(2):183-91. doi: 10.1016/j.thromres.2012.02.011. Epub 2012 Mar 15.
5
[Pharmacological sheet. Dabigatran, oral administration (Pradaxa)].
J Pharm Belg. 2012 Mar(1):37-8.
6
Dabigatran etexilate for prevention of venous thromboembolism.
Thromb Haemost. 2009 Jan;101(1):2-4.
7
Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials.
Thromb Res. 2010 Sep;126(3):175-82. doi: 10.1016/j.thromres.2010.03.021. Epub 2010 May 15.
8
Comparative effectiveness of new oral anticoagulants and standard thromboprophylaxis in patients having total hip or knee replacement: a systematic review.
Ann Intern Med. 2013 Aug 20;159(4):275-84. doi: 10.7326/0003-4819-159-4-201308200-00008.
9
Dabigatran: patient management in specific clinical settings.
Wien Klin Wochenschr. 2014 Sep;126(17-18):503-8. doi: 10.1007/s00508-014-0581-x. Epub 2014 Aug 20.
10
[Budgetary impact for the National Health System of apixaban prophylaxis of venous thromboembolism in patients undergoing total knee or hip replacement].
Rev Esp Salud Publica. 2012 Dec;86(6):601-12. doi: 10.4321/S1135-57272012000600006.
本文引用的文献
1
Dabigatran etexilate: pivotal trials for venous thromboembolism prophylaxis after hip or knee arthroplasty.
Clin Appl Thromb Hemost. 2009 Sep-Oct;15 Suppl 1:25S-31S. doi: 10.1177/1076029609340668. Epub 2009 Jul 31.
Zotero 插件